Horn & Co. Law Offices

Horn & Co. is the leading Israeli boutique law firm in the field of hi-tech and life sciences and is unique in its exclusive practice and expertise in this field. The firm’s founder, Yuval Horn, was recognized by the International Who’s Who of Life Sciences Lawyers as a Global Elite Thought Leader (2018-2023) and as one of the five leading individuals in the world in life sciences transactions (2013, 2015). Horn & Co.’s expertise includes the representation of clients in all aspects of their operations, focusing on their technology and intellectual property transactions, corporate and funding matters, and commercial contracting. Horn & Co. was founded in September 2009 and currently employs 16 lawyers and two articled clerks. The firm is known for its tailored, innovative structures, solutions, and advice in complex transactions and situations. Since 1993, both Yuval and his colleagues have represented numerous founders, companies, and investors in their transactions in the life science and technology sectors. Horn & Co. was chosen as the Israeli representative to Biolegis, the European network of leading law firms specializing in biotechnology and medical devices, in which one firm from each country is represented. Since 2008 Yuval has been a member and legal advisor of the Institutional Review Board of the Sheba Medical Center. Yuval served as the Co-Chair of the International Bar Association Technology Law Committee, and Co-chairs both the IBA Annual World Life Sciences Conference, and the IBA Annual M&A in the Technology Sector Conference. Yuval also teaches Life Sciences Entrepreneurship at Tel Aviv University Law Faculty.

Practice Areas

Corporate

Horn & Co. has significant recognized experience in the representation of biotechnology, medical devices, software, telecommunications, foodtech and cleantech companies. The lawyers at Horn & Co. have participated, for over 30 years, in numerous transactions representing companies, founders, academic institutions, and funds. The firm provides services with respect to all phases of a company’s lifecycle, in Israel, US, and the EU.
The firm’s corporate clients include companies of all sizes, from Israeli-based incubator companies to multinational companies conducting business in Israel. The firm provides services that include:
• Incorporation and founders’ agreements – setting up of companies in Israel, US, UK, and EU.
• Corporate restructuring – including redomiciled companies, mergers into publicly traded companies in Israel and in the US, and recapitalizations of share structures.
• Employment and consulting agreements – agreements for founders, advice on termination, and employment law procedures.
• Share option plans and employee benefits.
• Corporate governance.
• Formation of venture capital funds and relationships with their investors and portfolio companies, and representing venture capital funds in their investments.

Intellectual Property

The firm represents clients in all aspects of strategic transactions, including:
• Drafting, negotiating, and advising on IP-related agreements, including licensing, joint development, and prototype agreements with companies such as Bayer, Johnson & Johnson, Mayo Clinic, Pfizer, Edwards, Medtronic, Elevance (Anthem), Yahoo Japan, Dell, Bosch, Baxter, WuXi, Fosun, Intermountain Health, Cleveland Clinic, GE Medical, Smith and Nephew and Duoyuan.
• Data license agreements with leading healthcare providers, insurers, and companies.
• Representation of software companies in licensing, co-development, procurement, and related matters.
• Licensing transactions with technology transfer companies of academic and medical institutions worldwide.
• Clinical trial and CRO agreements with dozens of medical centers worldwide; and
• Manufacturing and distribution agreements.

Mergers and Acquisitions

The firm has a substantial track record in the representation of purchasers and targets in private and public merger and acquisition transactions. We regularly advise investors, companies, and boards of directors on mergers, including reverse mergers, mergers into publicly traded shells, asset purchases, and share acquisitions.
Recent examples Include:
• Biosight Ltd. in its merger with Ayala Pharmaceuticals Inc.
• Vascular Biogenics Ltd. in its merger with Notable Labs, Inc.
• INX Limited in its merger with Valdy Investments Ltd.
• Zebra Medical Vision Ltd. in its merger with Nano-x Technologies Ltd.
• Cellect Biotherapeutics Ltd. in its merger with Quoin Pharmaceuticals, Inc.
• Immunorizon Ltd. and its shareholders in its acquisition by Purple Biotech Ltd.

Regulation

Horn & Co. regularly advises international and Israeli companies with respect to their relationships with the Israeli government, especially the Ministry of Health and the Israel Innovation Authority. We assist in structuring both local and cross-border technology transactions in order to adequately conform to applicable regulations and lawful requirements. Horn & Co. is the Israeli representative to TRACE, an international organization whose member law firms specialize in anti-bribery, compliance and good governance regulation. (www.traceinternational.org)

Securities

Horn & Co. regularly advises Israeli and international clients on their full range of corporate finance transactions. We have special experience in the registration and issuance of securities of technology companies on US and Israeli securities exchanges, including IPOs, follow-on offerings, and PIPEs. We also advise board members and management of Tel Aviv Stock Exchange-traded technology companies with respect to corporate governance, ongoing activities, reporting requirements, and restrictions imposed by law and regulation. We represented the world’s first public offering of blockchain assets which are securities (Security Token Offering) initiated by INX Limited. INX raised more than $85 million, in consideration for INX Tokens offered under an F-1 registration statement which was cleared by the US Securities and Exchange Commission. Additional recent examples include:
• The incorporation of incubator companies, supported by funding from the Israeli Innovation Authority;
• Preliminary funding (convertible loan agreements, SAFEs, and similar structures);
• Seed rounds by angels and funds;
• Representation of Israeli and multinational companies in strategic investments;
• Registration and issuance of securities on US and Israeli securities exchanges, including IPOs, follow-on offerings, and PIPEs.

Venture Capital

Horn & Co. advises companies, founders, incubators, private investors, and venture capital funds with respect to their full range of finance transactions. We advise and represent the various aspects of the venture capital investment lifecycle, including the formation of venture capital funds since 1994, including Pontifax Ventures 6, Pontifax Medison (Venture Lending), and Pontifax Ventures 5 representation of dozens of technology, venture capital-backed companies, in their ongoing corporate and commercial lifecycles, including the representation of Inx Digital Company Canada in the investment and cooperation transactions with Republic.